Mangoceuticals Inc. (MGRX): Price/Earnings to Growth Multiple

Symbol and logo of brand Mangoceuticals, Inc. (MGRX)

Mangoceuticals, Inc. (MGRX) is actively scaling its MangoRx digital service, offering cutting-edge solutions for men's health. A PEG ratio analysis demonstrates a market consensus where the parameter value equals 0.00. Business efficiency is driven by AI-powered automation of screening and logistics, while high brand recognition in the US ensures patient trust in confidential telemedicine consultations.

Price/Earnings to Growth Ratio: MangoRx (MGRX) for 04/28/2023 - 11/10/2026

Metric breakdowns and analytics for Mangoceuticals, Inc. (MGRX)

- stock price and consensus target price:
Share Price mangorx.com|MGRX - Price Target Chart
- stock exchange capitalization data:
Market Valuation MangoRx|MGRX - Enterprise Value
- book value of equity indicators:
Book Value per Share Mangoceuticals|MGRX - Company Book Value|Capitalization to Book Value Ratio mangorx.com|MGRX - Company Total Assets
- debt obligations and liquidity statistics:
Debt to Capital Ratio Mangoceuticals, Inc.|MGRX - Long-Term Debt to Equity|Current Liabilities to Capital mangorx.com|MGRX - Company Aggregate Debts|Debt to Book Value MangoRx|MGRX - Company Long-Term Debts|Short-Term Debt Mangoceuticals|Quick Ratio mangorx.com
- company profitability and valuation multiples indicators:
MGRX - Net Income|Future Net Profit Mangoceuticals, Inc.|MGRX - P/E Multiple|Market Cap to Projected Earnings mangorx.com|MGRX - PEG Multiple|Enterprise Value to EBITDA Ratio MangoRx|MGRX - Operating profit EBITDA|Net earnings per share (EPS TTM) Mangoceuticals|MGRX - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months mangorx.com|MGRX - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Mangoceuticals, Inc.
General company analysis:MGRX (Mangoceuticals Inc.)
Manufactured product of MangoRx

Mangoceuticals, Inc. (MGRX) operates in the affordable luxury segment, where demand for telemedicine is moderately dependent on economic cycles. The PEG ratio compares the market value of earnings with their growth rate, revealing the asset's undervaluation. By analyzing changes in the PEG ratio, an investor assesses whether the quotes are adequate relative to the business's expansion rate. Values below one signal growth potential, provided the security's liquidity remains high. This confirms the fundamental stability of the model.

Competing companies

Hims & Hers Health, Inc. - Growth-Adjusted P/E Ratio|Price/Earnings to Growth Ratio Hinge Health Corp HNGE|TDOC - Price/Earnings to Growth Multiple|Talkspace, Inc. - PEG Multiple|LFMD - PEG Multiple|Amwell (AMWL) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio DRIO|VSEE (VSee Health Inc) - PEG Multiple|MNDR - Price to Net Income Growth Ratio|Price/Earnings to Growth Ratio Accolade (ACCD)|BTCY - Price to Earnings Adjusted for Growth Rate|PEG Multiple LYT (Lytus Technologies Holdings)|OTRK - Price/Earnings to Growth Multiple|SHL Telemedicine, Ltd. - PEG Multiple|Price to Earnings Adjusted for Growth Rate Thorne Research